Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP283308.RATrAGj9yrz6CLpK3XJXE2KbpXqfGN9F1fsgTSZqi53D0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP283308.RATrAGj9yrz6CLpK3XJXE2KbpXqfGN9F1fsgTSZqi53D0130_assertion type Assertion NP283308.RATrAGj9yrz6CLpK3XJXE2KbpXqfGN9F1fsgTSZqi53D0130_head.
- NP283308.RATrAGj9yrz6CLpK3XJXE2KbpXqfGN9F1fsgTSZqi53D0130_assertion wasGeneratedBy ECO_0000203 NP283308.RATrAGj9yrz6CLpK3XJXE2KbpXqfGN9F1fsgTSZqi53D0130_provenance.
- NP283308.RATrAGj9yrz6CLpK3XJXE2KbpXqfGN9F1fsgTSZqi53D0130_assertion wasDerivedFrom befree-2016 NP283308.RATrAGj9yrz6CLpK3XJXE2KbpXqfGN9F1fsgTSZqi53D0130_provenance.
- NP283308.RATrAGj9yrz6CLpK3XJXE2KbpXqfGN9F1fsgTSZqi53D0130_assertion SIO_000772 10803523 NP283308.RATrAGj9yrz6CLpK3XJXE2KbpXqfGN9F1fsgTSZqi53D0130_provenance.
- NP283308.RATrAGj9yrz6CLpK3XJXE2KbpXqfGN9F1fsgTSZqi53D0130_assertion evidence source_evidence_literature NP283308.RATrAGj9yrz6CLpK3XJXE2KbpXqfGN9F1fsgTSZqi53D0130_provenance.
- NP283308.RATrAGj9yrz6CLpK3XJXE2KbpXqfGN9F1fsgTSZqi53D0130_assertion description "[Furthermore, low E2F-1 expression and p16INK4A inactivation may serve as prognostic markers for patients with this type of lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP283308.RATrAGj9yrz6CLpK3XJXE2KbpXqfGN9F1fsgTSZqi53D0130_provenance.